TAMAR IBANEZ: Open Payments
NPI 1467095174 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 22 payments from 7 companies in 2025. Trend: 2023 $335 · 2024 $446 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $883 |
| Amgen Inc. | 9 | $401 |
| Novo Nordisk Inc | 5 | $181 |
| Novartis Pharmaceuticals Corporation | 4 | $137 |
| PFIZER INC. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Rapiblyk, Wegovy, LEQVIO, REPATHA, VYNDAQEL, Kerendia, JARDIANCE.
Industry payments across KS — which companies pay providers there.
